Drug Information

Drug General Information
Drug ID
D00CQQ
Former ID
DIB016572
Drug Name
TGFK09SD-ER
Indication Hypoactive sexual desire disorder [ICD10:F52.0] Phase 2 [550647]
Company
Fabre Kramer Pharmaceuticals Inc
Target and Pathway
Target(s) 5-hydroxytryptamine 1A receptor Target Info Modulator [549115]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
Serotonergic synapse
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (i) signalling events
WikiPathways Serotonin HTR1 Group and FOS Pathway
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 550647Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.
Ref 549115Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032503)